The released kojic acid can further inhibit the tyrosinase and melanin synthesis process
it's reacting to the junk that came along with it
The molecules in our cells routinely break down in a process called oxidation
Adverse effects observed in trials include: Nausea and vomiting particularly during dose escalation Diarrhoea or constipation Decreased appetite Injection site reactions Fatigue and dizziness Gallbladder-related events (including gallstones), consistent with effects observed with other GLP-1based therapies [9] Rare cases of pancreatitis , a risk associated with the GLP-1 receptor agonist class [10] [3] Because retatrutide is not licensed in the UK, the MHRA has not issued specific prescribing or dosing guidance for this compound
Following ischemic injury, neurodegeneration, infection or trauma in the brain or spinal cord, Shh signaling is activated and can improve neurological function by regulating inflammation, oxidative stress and apoptosis [15, 17,18,19,20,21,22]